Literature DB >> 32989328

BATF3 programs CD8+ T cell memory.

Marco A Ataide1, Karl Komander2, Konrad Knöpper2, Annika E Peters2, Hao Wu2, Sarah Eickhoff2, Tea Gogishvili2, Justus Weber3, Anika Grafen2, Axel Kallies4, Natalio Garbi5, Hermann Einsele3, Michael Hudecek3, Georg Gasteiger2, Michael Hölzel6, Martin Vaeth2, Wolfgang Kastenmüller7.   

Abstract

Antiviral CD8+ T cell responses are characterized by an initial activation/priming of T lymphocytes followed by a massive proliferation, subset differentiation, population contraction and the development of a stable memory pool. The transcription factor BATF3 has been shown to play a central role in the development of conventional dendritic cells, which in turn are critical for optimal priming of CD8+ T cells. Here we show that BATF3 was expressed transiently within the first days after T cell priming and had long-lasting T cell-intrinsic effects. T cells that lacked Batf3 showed normal expansion and differentiation, yet succumbed to an aggravated contraction and had a diminished memory response. Vice versa, BATF3 overexpression in CD8+ T cells promoted their survival and transition to memory. Mechanistically, BATF3 regulated T cell apoptosis and longevity via the proapoptotic factor BIM. By programing CD8+ T cell survival and memory, BATF3 is a promising molecule to optimize adoptive T cell therapy in patients.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32989328     DOI: 10.1038/s41590-020-0786-2

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  50 in total

1.  Repression of IL-2 promoter activity by the novel basic leucine zipper p21SNFT protein.

Authors:  M Iacobelli; W Wachsman; K L McGuire
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

2.  Spatiotemporally Distinct Interactions with Dendritic Cell Subsets Facilitates CD4+ and CD8+ T Cell Activation to Localized Viral Infection.

Authors:  Jyh Liang Hor; Paul G Whitney; Ali Zaid; Andrew G Brooks; William R Heath; Scott N Mueller
Journal:  Immunity       Date:  2015-08-18       Impact factor: 31.745

3.  Robust Anti-viral Immunity Requires Multiple Distinct T Cell-Dendritic Cell Interactions.

Authors:  Sarah Eickhoff; Anna Brewitz; Michael Y Gerner; Frederick Klauschen; Karl Komander; Hiroaki Hemmi; Natalio Garbi; Tsuneyasu Kaisho; Ronald Nathan Germain; Wolfgang Kastenmüller
Journal:  Cell       Date:  2015-08-18       Impact factor: 41.582

Review 4.  CD4(+) T-cell help amplifies innate signals for primary CD8(+) T-cell immunity.

Authors:  Sammy Bedoui; William R Heath; Scott N Mueller
Journal:  Immunol Rev       Date:  2016-07       Impact factor: 12.988

Review 5.  AP-1 as a regulator of cell life and death.

Authors:  Eitan Shaulian; Michael Karin
Journal:  Nat Cell Biol       Date:  2002-05       Impact factor: 28.824

Review 6.  AP-1 function and regulation.

Authors:  M Karin; Z g Liu; E Zandi
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

Review 7.  Transcriptional control of effector and memory CD8+ T cell differentiation.

Authors:  Susan M Kaech; Weiguo Cui
Journal:  Nat Rev Immunol       Date:  2012-10-19       Impact factor: 53.106

Review 8.  Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks.

Authors:  Theresa L Murphy; Roxane Tussiwand; Kenneth M Murphy
Journal:  Nat Rev Immunol       Date:  2013-06-21       Impact factor: 53.106

9.  BATF-JUN is critical for IRF4-mediated transcription in T cells.

Authors:  Peng Li; Rosanne Spolski; Wei Liao; Lu Wang; Theresa L Murphy; Kenneth M Murphy; Warren J Leonard
Journal:  Nature       Date:  2012-09-19       Impact factor: 49.962

10.  Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor.

Authors:  Gary E Grajales-Reyes; Arifumi Iwata; Jörn Albring; Xiaodi Wu; Roxane Tussiwand; Wumesh Kc; Nicole M Kretzer; Carlos G Briseño; Vivek Durai; Prachi Bagadia; Malay Haldar; Jörg Schönheit; Frank Rosenbauer; Theresa L Murphy; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2015-06-08       Impact factor: 25.606

View more
  22 in total

1.  Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-Priming.

Authors:  Federico Simonetta; Juliane K Lohmeyer; Toshihito Hirai; Kristina Maas-Bauer; Maite Alvarez; Arielle S Wenokur; Jeanette Baker; Amin Aalipour; Xuhuai Ji; Samuel Haile; Crystal L Mackall; Robert S Negrin
Journal:  Clin Cancer Res       Date:  2021-08-10       Impact factor: 12.531

2.  Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains.

Authors:  Khloe S Gordon; Taeyoon Kyung; Caleb R Perez; Patrick V Holec; Azucena Ramos; Angela Q Zhang; Yash Agarwal; Yunpeng Liu; Catherine E Koch; Alina Starchenko; Brian A Joughin; Douglas A Lauffenburger; Darrell J Irvine; Michael T Hemann; Michael E Birnbaum
Journal:  Nat Biomed Eng       Date:  2022-06-16       Impact factor: 29.234

3.  A vaccine targeting resistant tumours by dual T cell plus NK cell attack.

Authors:  Maxence O Dellacherie; Aileen Li; Shiwei Zheng; Soumya Badrinath; Xixi Zhang; Miguel Sobral; Jason W Pyrdol; Kathryn L Smith; Yuheng Lu; Sabrina Haag; Hamza Ijaz; Fawn Connor-Stroud; Tsuneyasu Kaisho; Glenn Dranoff; Guo-Cheng Yuan; David J Mooney; Kai W Wucherpfennig
Journal:  Nature       Date:  2022-05-25       Impact factor: 69.504

4.  A genome-scale screen for synthetic drivers of T cell proliferation.

Authors:  Mateusz Legut; Zoran Gajic; Maria Guarino; Zharko Daniloski; Jahan A Rahman; Xinhe Xue; Congyi Lu; Lu Lu; Eleni P Mimitou; Stephanie Hao; Teresa Davoli; Catherine Diefenbach; Peter Smibert; Neville E Sanjana
Journal:  Nature       Date:  2022-03-16       Impact factor: 69.504

5.  Effector differentiation downstream of lineage commitment in ILC1s is driven by Hobit across tissues.

Authors:  Christin Friedrich; Renske L R E Taggenbrock; Rémi Doucet-Ladevèze; Gosia Golda; Rebekka Moenius; Panagiota Arampatzi; Natasja A M Kragten; Katharina Kreymborg; Mercedes Gomez de Agüero; Wolfgang Kastenmüller; Antoine-Emmanuel Saliba; Dominic Grün; Klaas P J M van Gisbergen; Georg Gasteiger
Journal:  Nat Immunol       Date:  2021-08-30       Impact factor: 25.606

6.  Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer.

Authors:  Christopher S Garris; Jeffrey L Wong; Jeffrey V Ravetch; David A Knorr
Journal:  Sci Transl Med       Date:  2021-05-19       Impact factor: 17.956

Review 7.  The role of dendritic cells in cancer and anti-tumor immunity.

Authors:  Ariel E Marciscano; Niroshana Anandasabapathy
Journal:  Semin Immunol       Date:  2021-05-20       Impact factor: 11.130

8.  Resistance to Experimental Visceral Leishmaniasis in Mice Infected With Leishmania infantum Requires Batf3.

Authors:  Manuel Soto; Laura Ramírez; José Carlos Solana; Emma C L Cook; Elena Hernández-García; Sara Charro-Zanca; Ana Redondo-Urzainqui; Rosa M Reguera; Rafael Balaña-Fouce; Salvador Iborra
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 7.561

9.  The AP-1 transcription factors c-Jun and JunB are essential for CD8α conventional dendritic cell identity.

Authors:  Philipp Novoszel; Barbara Drobits; Martin Holcmann; Cristiano De Sa Fernandes; Roland Tschismarov; Sophia Derdak; Thomas Decker; Erwin F Wagner; Maria Sibilia
Journal:  Cell Death Differ       Date:  2021-03-23       Impact factor: 15.828

10.  Type 1 conventional dendritic cells and interferons are required for spontaneous CD4+ and CD8+ T-cell protective responses to breast cancer.

Authors:  Raphaël Mattiuz; Carine Brousse; Marc Ambrosini; Jean-Charles Cancel; Gilles Bessou; Julie Mussard; Amélien Sanlaville; Christophe Caux; Nathalie Bendriss-Vermare; Jenny Valladeau-Guilemond; Marc Dalod; Karine Crozat
Journal:  Clin Transl Immunology       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.